Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation

Freek W. A. Verheugt, Kurt Huber, Peter Clemmensen, Jean-Philippe Collet, Thomas Cuisset, Felicita Andreotti

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation'. Insieme formano una fingerprint unica.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science